SUBSCRIBE
SUBSCRIBE
News   Drug Development

Pfizer Inc.'s Crizotinib Wipes Out Rare Lymphoma in Two Test Cases

February 24, 2011 | 
1 min read

Bloomberg -- Pfizer Inc.’s experimental drug to treat a type of lung cancer appeared to wipe out a rare form of lymphoma in two severely ill patients in test cases reported by doctors.

Clinical research Postmarket research
Pfizer
MORE ON THIS TOPIC
Cardiovascular disease
Merck’s Winrevair Cuts Morbidity, Mortality Risk by Over 75% in Phase III PAH Study
April 1, 2025
 · 
2 min read
 · 
Tristan Manalac
Climb up, hand help businessman build ladder
Diabetes
Vertex Cuts Diabetes Asset, but Analysts Keen on Phase III Option
March 31, 2025
 · 
4 min read
 · 
Annalee Armstrong
World heart day. Sketch style human heart. Retro halftone hands reaching out to each other. Modern collage. Valentines day banner. Healthcare medical concept. Healthy lifestyle.
Cardiovascular disease
Lilly’s RNA Silencer Lowers Key Cardiovascular Biomarker by Almost 94%
March 31, 2025
 · 
2 min read
 · 
Tristan Manalac
Success roadmap journey, milestone or career path achievement, route or pathway to achieve goals, accomplishment, assessment or way to success, businessman look at achievement milestone to success.
GLP-1
Novo Paints Murky Cardio Picture for Semaglutide Franchise
March 31, 2025
 · 
2 min read
 · 
Tristan Manalac